Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1955297rdf:typepubmed:Citationlld:pubmed
pubmed-article:1955297lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C0022616lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:1955297lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:1955297pubmed:issue2lld:pubmed
pubmed-article:1955297pubmed:dateCreated1992-1-2lld:pubmed
pubmed-article:1955297pubmed:abstractTextEighteen dyslipidaemic patients affected with moderate hypertension were studied before and after short-term treatment with ketanserin (40 mg/die) on hypocaloric (22-25 kcal/kg/die) and normosodic-normopotassic diet. Student's t test applied to the determinations revealed a significant reduction of systolic and diastolic blood pressure (SBP, p less than 0.001, DBP p less than 0.001), total cholesterol (p less than 0.001) and triglycerides (p less than 0.006). The results suggest that ketanserin is an effective hypotensive drug and its association with a hypocaloric diet promotes a decrease in plasma lipids.lld:pubmed
pubmed-article:1955297pubmed:languageenglld:pubmed
pubmed-article:1955297pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955297pubmed:citationSubsetIMlld:pubmed
pubmed-article:1955297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955297pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1955297pubmed:statusMEDLINElld:pubmed
pubmed-article:1955297pubmed:issn0250-0868lld:pubmed
pubmed-article:1955297pubmed:authorpubmed-author:ScavoDDlld:pubmed
pubmed-article:1955297pubmed:authorpubmed-author:SelliniMMlld:pubmed
pubmed-article:1955297pubmed:authorpubmed-author:LetiziaCClld:pubmed
pubmed-article:1955297pubmed:issnTypePrintlld:pubmed
pubmed-article:1955297pubmed:volume13lld:pubmed
pubmed-article:1955297pubmed:ownerNLMlld:pubmed
pubmed-article:1955297pubmed:authorsCompleteYlld:pubmed
pubmed-article:1955297pubmed:pagination91-3lld:pubmed
pubmed-article:1955297pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:meshHeadingpubmed-meshheading:1955297-...lld:pubmed
pubmed-article:1955297pubmed:year1991lld:pubmed
pubmed-article:1955297pubmed:articleTitleHaemodynamic and metabolic effects of ketanserin in dyslipidaemic hypertensive subjects.lld:pubmed
pubmed-article:1955297pubmed:affiliationI Patologia Speciale Medica, University of Rome La Sapienza, Italy.lld:pubmed
pubmed-article:1955297pubmed:publicationTypeJournal Articlelld:pubmed